SPARC’s Baclofen GRS fails to meet primary end point in placebo controlled studies
The study consisted of a total of 293 subjects in the intent to treat population
Author
IIT Roorkee scientists identify drug to fight Chikungunya virus
The molecular details revealed in the study can be further utilised to design piperazine derivative drugs that are more potent and…
Granules India gets EIR from USFDA for OmniChem facility
OmniChem facility is operated by 50:50 joint venture of Granules India and Ajinimoto OmniChem
Novartis divests anti-infectives brands to Samara Capital
The portfolio of brands acquired focus on anti-infectives largely catering to the women's health and gynaecology segment
Fosun Pharma acquires 74 per cent stake in Gland Pharma for $1.09 bn
Following the completion of the acquisition, Gland Pharma has become an indirect non-wholly owned subsidiary of Fosun Pharma and…
MoH&FW to introduce new TB drug in controlled manner
As a pilot, 400 courses of Delamanid will be rolled out in five to six states as part of the conditional access programme under…
Aptar Pharma to highlight key innovations in drug delivery at CPHI Worldwide
The company will present three pharma insight briefings that will highlight its latest innovations and developments in the…
7th NGBT conference held in Bhubaneswar
The conference featured developments in genomics technologies and their applications in life sciences
Lupin appoints Jim Loerop as Chief Corporate Development Officer
He will be responsible for the company’s global M&A and business development functions